Select language:  
1800 620 420
Close menu

Professor Ulrich Steidl describes research as “a team sport”

Ulrich Steidl discusses his work as an experimental haematologist in MDS and AML.

  • Acute myeloid leukaemia
  • Myelodysplastic syndromes
  • Research
Read more
Dr Ulrich Steidl

Haemo-globetrotter Bryan has blood tranfusions on his travels

Veteran traveller Bryan Mitchell, get treatment for his MDS as he journeys from country to country… until COVID-19 put a stop to his travels.  

  • Myelodysplastic syndromes
  • Myeloproliferative neoplasms
Read more
Bryan sitting in a boat, with the Murray cod caught on a fishing trip at Lake Mulwala

Myelodysplastic neoplasms (MDS)

  • Myelodysplastic syndromes
Read more

Quest to better understand MDS and find out more effective therapies

When someone with MDS is treated with azacitidine (Vidaza®), it takes six months to find out if they are responding to the drug. Dr Unnikrishnan is working to change that.

  • Myelodysplastic syndromes
  • Research
Read more
Dr Ashwin Unnikrishnan

Merrick from Berwick has “reported for duty” since 2012

For almost eight years, this has been Brian Merrick’s greeting when entering the treatment room in Melbourne for his monthly round of azacitidine (Vidaza®) injections on a clinical trial.

  • Myelodysplastic syndromes
Read more
Brian Merrick

Stepping up to the challenge of curing MDS

Louise thought it was her busy job that was making her tired, when she received a shock MDS diagnosis.

  • Myelodysplastic syndromes
Read more
Brett and Louise in Dubrovnik

Searching for biomarkers and better treatments for B-cell lymphomas

Professor Ricky Johnstone hopes to find new research treatments for B-cell lymphomas.

  • Acute myeloid leukaemia
  • Myelodysplastic syndromes
  • Myeloproliferative neoplasms
Read more
Dr Pilar Dominguez with Professor Ricky Johnstone

Talking myelodysplastic syndrome with Dr Melita Kenealy

From current treatments to living with the disease, Dr Melita Kenealy covers the basics of MDS.

  • Myelodysplastic syndromes
Read more
myelodysplastic-syndrome-Dr-Melita-Kenealy

Improving the “wait and see” approach to treatment for high-risk blood cancer

Researchers have discovered why half of patients with a type of high-risk blood cancer will not respond to a common treatment.

  • Myelodysplastic syndromes
  • Research
Read more
Dr Ashwin Unnikrishnan